More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

被引:115
作者
Alexandroff, A. B. [1 ]
Pauriah, M. [2 ]
Camp, R. D. R. [3 ]
Lang, C. C. [2 ]
Struthers, A. D. [2 ]
Armstrong, D. J. [4 ]
机构
[1] Leicester Royal Infirm, Dept Dermatol, Leicester LE1 5WW, Leics, England
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Div Med & Therapeut, Dundee DD1 9SY, Scotland
[3] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[4] Altnagelvin Hosp, Dept Rheumatol, Londonderry, North Ireland
关键词
atherosclerosis; cardiovascular disease; metabolic syndrome; psoriasis; tumour necrosis factor-alpha; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; CORONARY-ARTERY-DISEASE; EVIDENT CARDIOVASCULAR-DISEASE; PLACEBO-CONTROLLED TRIAL; TOLL-LIKE-RECEPTORS; RHEUMATOID-ARTHRITIS; RISK-FACTORS; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION;
D O I
10.1111/j.1365-2133.2009.09281.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is now growing evidence that psoriasis, like other inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus, is a systemic disorder that is associated with enhanced atherosclerosis and risk of coronary artery disease. Here we summarize the available epidemiological evidence for this association and analyse pathogenic features that are common to psoriasis and atherosclerosis. Further prospective studies are urgently needed to extend knowledge of the risk of cardiovascular morbidity and mortality in patients with psoriasis and to confirm the degree to which treatment of psoriasis reduces this risk. Nevertheless, existing data are sufficient to indicate that severe psoriasis should be more widely recognized as a potential risk factor for cardiovascular disease and should be considered with the established factors when formulating strategies for the management of cardiovascular risk.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 126 条
[91]   Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development [J].
Schoneveld, AH ;
Nijhuis, MMO ;
van Middelaar, B ;
Laman, JD ;
de Kleijn, D ;
Pasterkamp, G .
CARDIOVASCULAR RESEARCH, 2005, 66 (01) :162-169
[92]   IDENTIFICATION OF C5ADES ARG AND AN ANIONIC NEUTROPHIL-ACTIVATING PEPTIDE (ANAP) IN PSORIATIC SCALES [J].
SCHRODER, JM ;
CHRISTOPHERS, E .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 87 (01) :53-58
[93]   C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice [J].
Shagdarsuren, Erdenechimeg ;
Bidzhekov, Kiril ;
Djalali-Talab, Yassin ;
Liehn, Elisa A. ;
Hristov, Mihail ;
Matthijsen, Robert A. ;
Buurman, Wim A. ;
Zernecke, Alma ;
Weber, Christian .
CIRCULATION, 2008, 117 (01) :70-78
[94]   The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study [J].
Shapiro, Jonathan ;
Cohen, Arnon D. ;
David, Michael ;
Hodak, Emilia ;
Chodik, Gabi ;
Viner, Anna ;
Kremer, Eyal ;
Heymann, Anthony .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) :629-634
[95]   Efficacy of simvastatin in plaque psoriasis: A pilot study [J].
Shirinsky, Ivan Valeiyevich ;
Shirinsky, Valery Stepanovich .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (03) :529-531
[96]  
Singh TP, 2008, BRIT J DERMATOL, V159, P1398
[97]   Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis [J].
Sommer, Dorothea M. ;
Jenisch, Stefan ;
Suchan, Michael ;
Christophers, Enno ;
Weichenthal, Michael .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 298 (07) :321-328
[98]   Inflammation in atherosclerosis and psoriasis:: common pathogenic mechanisms and the potential for an integrated treatment approach [J].
Spaeh, F. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 :10-17
[99]   DIABETES, OTHER RISK-FACTORS, AND 12-YR CARDIOVASCULAR MORTALITY FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
STAMLER, J ;
VACCARO, O ;
NEATON, JD ;
WENTWORTH, D .
DIABETES CARE, 1993, 16 (02) :434-444
[100]   Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model [J].
Stenderup, K. ;
Rosada, C. ;
Worsaae, A. ;
Dagnaes-Hansen, F. ;
Steiniche, T. ;
Hasselager, E. ;
Iversen, L. F. ;
Zahn, S. ;
Woldike, H. ;
Lindgreen Holmberg, H. ;
Romer, J. ;
Kragballe, K. ;
Clausen, J. T. ;
Dam, T. N. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (02) :284-296